15 Analysts Assess Synopsys: What You Need To Know
Ratings for Synopsys (NASDAQ:SNPS) were provided by 15 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 5 | 4 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 5 | 5 | 3 | 0 | 0 |
Analysts have recently evaluated Synopsys and provided 12-month price targets. The average target is $556.13, accompanied by a high estimate of $650.00 and a low estimate of $445.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 0.21%.
Breaking Down Analyst Ratings: A Detailed Examination
The perception of Synopsys by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Blair Abernethy | Rosenblatt | Maintains | Buy | $560.00 | $560.00 |
| Clarke Jeffries | Piper Sandler | Lowers | Neutral | $520.00 | $602.00 |
| Lee Simpson | Morgan Stanley | Raises | Overweight | $550.00 | $510.00 |
| Harlan Sur | JP Morgan | Raises | Overweight | $650.00 | $600.00 |
| Joe Quatrochi | Wells Fargo | Raises | Equal-Weight | $500.00 | $445.00 |
| Jason Celino | Keybanc | Raises | Overweight | $600.00 | $575.00 |
| Vivek Arya | B of A Securities | Raises | Buy | $560.00 | $500.00 |
| Blair Abernethy | Rosenblatt | Maintains | Buy | $560.00 | $560.00 |
| Charles Shi | Needham | Raises | Buy | $580.00 | $550.00 |
| Clarke Jeffries | Piper Sandler | Lowers | Overweight | $602.00 | $630.00 |
| Blair Abernethy | Rosenblatt | Lowers | Buy | $560.00 | $605.00 |
| Vivek Arya | B of A Securities | Lowers | Neutral | $500.00 | $525.00 |
| Jason Celino | Keybanc | Lowers | Overweight | $575.00 | $590.00 |
| Joe Quatrochi | Wells Fargo | Lowers | Equal-Weight | $445.00 | $550.00 |
| Kelsey Chia | Citigroup | Announces | Buy | $580.00 | - |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Synopsys. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Synopsys compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Synopsys's stock. This comparison reveals trends in analysts' expectations over time.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Synopsys's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Synopsys analyst ratings.
All You Need to Know About Synopsys
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Synopsys: Delving into Financials
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Synopsys's revenue growth over a period of 3M has been noteworthy. As of 31 October, 2025, the company achieved a revenue growth rate of approximately 37.83%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Synopsys's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 19.9%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Synopsys's ROE excels beyond industry benchmarks, reaching 1.6%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Synopsys's ROA stands out, surpassing industry averages. With an impressive ROA of 0.93%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Synopsys's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.5, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
The Significance of Analyst Ratings Explained
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.